Robert D. Leone
Impact in
- Physiology top 1%
- Adenosine and Purinergic Signaling
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
-
- Adenosine and Purinergic Signaling 3
- Co-authors
- Leisha A. Emens (1 shared paper)Jonathan D. Powell (9 shared papers)Chirag H. Patel (3 shared papers)Min Hee Oh (2 shared papers)Judson M. Englert (2 shared papers)Jiayu Wen (3 shared papers)Im‐Hong Sun (3 shared papers)Im-Meng Sun (2 shared papers)
- Journals
- Cancer Immunology Research (2 papers)Cancer Research (2 papers)Pharmaceutics (1 paper)Science Advances (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesCanadaCzechia
In The Last Decade
Robert D. Leone
20 papers receiving 2.5k citations
Robert D. Leone's Hit Papers
Peers
Comparison fields: 5 of 91
- Physiology 228
- Cancer Research 658
- Oncology 738
- Immunology 483
- Biochemistry 155
Countries citing papers authored by Robert D. Leone
This map shows the geographic impact of Robert D. Leone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Leone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Leone more than expected).
Fields of papers citing papers by Robert D. Leone
This network shows the impact of papers produced by Robert D. Leone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Leone. The network helps show where Robert D. Leone may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert D. Leone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion Hit paper breakdown → | 2019 | 936 |
| 2 | Targeting adenosine for cancer immunotherapy Hit paper breakdown → | 2018 | 462 |
| 3 | 2014 | 323 | |
| 4 | 2019 | 225 | |
| 5 | 2018 | 168 | |
| 6 | 2022 | 101 | |
| 7 | 2022 | 70 | |
| 8 | 2013 | 55 | |
| 9 | 2024 | 36 | |
| 10 | 2021 | 34 | |
| 11 | 2023 | 23 | |
| 12 | 2024 | 17 | |
| 13 | 2000 | 13 | |
| 14 | Are aspen sterols and steryl esters changed structurally by kraft pulping and bleaching | 1999 | 12 |
| 15 | 2022 | 4 | |
| 16 | 2025 | 4 | |
| 17 | Why fungal growth is less effective in aspen heartwood than in aspen sapwood | 1997 | 3 |
| 18 | 2016 | 3 | |
| 19 | Encapsulation of crystalline topotecan in sphingosomes: a formulation suitable for clinical development | 2005 | 1 |
| 20 | 2023 | 1 |
About Robert D. Leone
Robert D. Leone is a scholar working on Cancer Research, Physiology, Oncology, Immunology and Structural Biology, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), T-cell and B-cell Immunology (3 papers), Adenosine and Purinergic Signaling (3 papers), Immune cells in cancer (2 papers), Autophagy in Disease and Therapy (2 papers), RNA Interference and Gene Delivery (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Physiology (228 citations), Cancer Research (658 citations), Oncology (738 citations), Immunology (483 citations) and Biochemistry (155 citations). Robert D. Leone has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Leisha A. Emens, Jonathan D. Powell, Chirag H. Patel, Min Hee Oh, Judson M. Englert, Jiayu Wen, Im‐Hong Sun, Im-Meng Sun, Rana Rais and Liang Zhao. Their work appears in journals such as Cancer Immunology Research, Cancer Research, Pharmaceutics, Science Advances and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.